Sharps Technology EBITDA 2022-2025 | STSS
Sharps Technology ebitda from 2022 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
Sharps Technology Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-7 |
| 2023 | $-9 |
| 2022 | $-7 |
| 2021 | $-4 |
|
Sharps Technology Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-3 |
| 2025-03-31 | $-1 |
| 2024-12-31 | $-2 |
| 2024-09-30 | $-2 |
| 2024-06-30 | $-2 |
| 2024-03-31 | $-2 |
| 2023-12-31 | $-3 |
| 2023-09-30 | $-2 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-2 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $-2 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-1 |
| 2021-12-31 | $-1 |
| 2021-09-30 | $-1 |
| 2021-06-30 | $-1 |
| 2021-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.114B | $0.000B |
| Sharps Technology Inc. is a medical device company offering patented, best-in-class, single use smart safety syringe products. Sharps Technology Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.907B | 25.23 |
| EssilorLuxottica (ESLOY) | France | $167.835B | 0.00 |
| Boston Scientific (BSX) | United States | $149.593B | 34.21 |
| Stryker (SYK) | United States | $135.768B | 26.96 |
| Medtronic (MDT) | Ireland | $118.854B | 16.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.878B | 0.00 |
| Agilent Technologies (A) | United States | $41.493B | 26.85 |
| ResMed (RMD) | United States | $36.500B | 25.26 |
| GE HealthCare Technologies (GEHC) | United States | $33.472B | 16.01 |
| Koninklijke Philips (PHG) | Netherlands | $27.202B | 17.77 |
| Terumo (TRUMY) | Japan | $24.340B | 28.84 |
| Insulet (PODD) | United States | $22.536B | 69.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.585B | 10.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.234B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.124B | 7.37 |
| Bio-Rad Laboratories (BIO) | United States | $8.292B | 29.81 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| ICU Medical (ICUI) | United States | $3.437B | 21.82 |
| Lantheus Holdings (LNTH) | United States | $3.361B | 10.24 |
| Haemonetics (HAE) | United States | $3.299B | 14.68 |
| Envista Holdings (NVST) | United States | $3.297B | 18.92 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.907B | 13.26 |
| LeMaitre Vascular (LMAT) | United States | $1.992B | 40.09 |
| Curaleaf Holdings (CURLF) | Canada | $1.977B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.961B | 4.91 |
| Phibro Animal Health (PAHC) | United States | $1.858B | 18.56 |
| Green Thumb Industries (GTBIF) | United States | $1.612B | 70.64 |
| AtriCure (ATRC) | United States | $1.590B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.471B | 0.00 |
| Neogen (NEOG) | United States | $1.382B | 26.50 |
| Kestra Medical Technologies (KMTS) | United States | $1.359B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.340B | 8.62 |
| AdaptHealth (AHCO) | United States | $1.272B | 18.43 |
| BioLife Solutions (BLFS) | United States | $1.266B | 375.57 |
| InMode (INMD) | Israel | $0.923B | 10.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.792B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.500B | 17.23 |
| SNDL (SNDL) | Canada | $0.491B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.474B | 0.00 |
| Evolus (EOLS) | United States | $0.457B | 0.00 |
| Omeros (OMER) | United States | $0.449B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.438B | 0.00 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.391B | 0.00 |
| Cerus (CERS) | United States | $0.307B | 0.00 |
| Brainsway (BWAY) | Israel | $0.306B | 62.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.294B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.263B | 155.67 |
| High Tide (HITI) | Canada | $0.262B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.254B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.251B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.243B | 19.36 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Owens & Minor (OMI) | United States | $0.228B | 2.29 |
| Organigram Global (OGI) | Canada | $0.222B | 0.00 |
| Exagen (XGN) | United States | $0.214B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.210B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 16.18 |
| FitLife Brands (FTLF) | United States | $0.174B | 21.46 |
| OraSure Technologies (OSUR) | United States | $0.167B | 0.00 |
| Apyx Medical (APYX) | United States | $0.157B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.140B | 0.00 |
| Biote (BTMD) | United States | $0.122B | 4.92 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 13.49 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.00 |
| Nephros (NEPH) | United States | $0.046B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Zynex (ZYXI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.65 |
| Modular Medical (MODD) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |